Published in Eur Radiol on May 11, 2013
Non-Gaussian analysis of diffusion weighted imaging in head and neck at 3T: a pilot study in patients with nasopharyngeal carcinoma. PLoS One (2014) 1.01
Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study. Eur Radiol (2014) 0.98
Comparison of fitting methods and b-value sampling strategies for intravoxel incoherent motion in breast cancer. Magn Reson Med (2014) 0.89
Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility. World J Radiol (2016) 0.84
Multiparametric MR Imaging in Abdominal Malignancies. Magn Reson Imaging Clin N Am (2016) 0.83
Whole-body intravoxel incoherent motion imaging. Eur Radiol (2015) 0.83
Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy. Eur Radiol (2013) 0.81
Simple and reliable determination of intravoxel incoherent motion parameters for the differential diagnosis of head and neck tumors. PLoS One (2014) 0.79
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single Center Analysis. Medicine (Baltimore) (2016) 0.76
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases. Onco Targets Ther (2016) 0.75
Intravoxel incoherent motion model-based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma. Onco Targets Ther (2016) 0.75
Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging. Oncotarget (2017) 0.75
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology (1986) 11.58
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology (1988) 8.08
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med (2005) 6.17
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology (2008) 4.46
Diffusion-weighted MR imaging of the liver. Radiology (2010) 3.50
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34
Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol (2011) 2.33
Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology (1999) 2.19
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol (2007) 2.07
Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging (2010) 1.96
Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol (1998) 1.80
Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology (2008) 1.78
The capillary network: a link between IVIM and classical perfusion. Magn Reson Med (1992) 1.65
Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging (2011) 1.60
Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol (2009) 1.52
Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol (2012) 1.51
Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging (2009) 1.50
Optimised diffusion-weighting for measurement of apparent diffusion coefficient (ADC) in human brain. Magn Reson Imaging (1997) 1.50
An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med (2010) 1.48
Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology (2002) 1.45
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging (2008) 1.44
Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology (2008) 1.41
Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol (2007) 1.39
In vivo MR measurements of regional arterial and venous blood volume fractions in intact rat brain. Magn Reson Med (2000) 1.37
Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology (2010) 1.36
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol (2010) 1.36
Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34
Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging (2008) 1.32
Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology (2012) 1.25
Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging (2006) 1.16
Influence of cardiac motion on diffusion-weighted magnetic resonance imaging of the liver. MAGMA (2009) 1.15
Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results. AJR Am J Roentgenol (2009) 1.15
Measurement of the apparent diffusion coefficient in the liver: is it a reliable index for hepatic disease diagnosis? Radiat Med (2006) 1.05
Liver diffusion-weighted MR imaging: the tower of Babel? Eur Radiol (2010) 1.05
Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed (2006) 1.01
Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods. J Magn Reson Imaging (2012) 1.00
Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development. Eur J Cancer (2012) 0.99
Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques. Eur Radiol (2012) 0.99
Reproductibility of apparent diffusion coefficients measurements in diffusion-weighted MRI of the abdomen with different b values. Eur J Radiol (2011) 0.99
Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis. Eur Radiol (2012) 0.94
Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions. World J Radiol (2009) 0.92
Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. Eur Radiol (2012) 0.90
Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. Magn Reson Imaging (2012) 0.88
Low b-value diffusion-weighted imaging: emerging applications in the body. J Magn Reson Imaging (2012) 0.88
A versatile flow phantom for intravoxel incoherent motion MRI. Magn Reson Med (2011) 0.87
Diffusion-weighted MR imaging for liver lesion characterization: a critical look. Radiology (2012) 0.86
Evaluation of true diffusion, perfusion factor, and apparent diffusion coefficient in non-necrotic liver metastases and uncomplicated liver hemangiomas using black-blood echo planar imaging. Eur J Radiol (2007) 0.83
Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol (2011) 0.81
Diffusion-weighted MRI for detecting liver metastases: importance of the b-value. Eur Radiol (2010) 0.77
[Diffusion-weighted MR imaging of liver pathology: principles and clinical applications]. J Radiol (2010) 0.75
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology (1999) 6.50
MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology (2000) 2.77
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol (2002) 2.54
Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology (1996) 2.38
Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest (1998) 2.12
Dacryoliths: nonsurgical fluoroscopically guided treatment during dacryocystoplasty. Radiology (1999) 1.89
Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology (2000) 1.82
Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology (1997) 1.79
Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol (1998) 1.78
Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol (2007) 1.76
Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation (2001) 1.60
Dysembryoplastic neuroepithelial tumors: MR and CT evaluation. AJNR Am J Neuroradiol (1996) 1.53
Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology (1997) 1.52
[MRI in patients with cardiac pacemakers: in vitro and in vivo evaluation at 0.5 tesla]. Rofo (1998) 1.48
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol (2001) 1.47
Positional venous MR angiography: an operator-independent tool to evaluate cerebral venous outflow hemodynamics. AJNR Am J Neuroradiol (2011) 1.44
Proton magnetic resonance spectroscopy in Kennedy syndrome. Arch Neurol (1999) 1.44
Treatment of benign prostatic hyperplasia by occlusion of the impaired urogenital venous system - first experience. Rofo (2014) 1.39
Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging (2000) 1.33
Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging (1999) 1.32
Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia. Am J Hum Genet (2006) 1.30
MR imaging--guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology (2001) 1.28
Diffusion tensor pyramidal tractography in patients with anterior choroidal artery infarcts. AJNR Am J Neuroradiol (2007) 1.22
Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology (2000) 1.14
Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J Exp Med (1996) 1.13
Combined intrauterine and ovarian pregnancy mimicking ovarian malignant tumor: imaging findings. AJR Am J Roentgenol (1995) 1.13
Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology (2000) 1.11
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology (2000) 1.10
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging (2013) 1.08
Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy (2002) 1.07
Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol (2006) 1.06
Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease. Eur Radiol (2004) 1.05
Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology (2000) 1.03
Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology (2001) 1.02
Taste does not determine daily intake of dilute sugar solutions in mice. Am J Physiol Regul Integr Comp Physiol (2010) 1.02
Treatment monitoring and response prediction with proton MR spectroscopy in AD. Neurology (2006) 1.00
Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease. AJNR Am J Neuroradiol (2008) 0.98
Diffusion- and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. Stroke (1999) 0.98
Pulmonary hypertension in patients with chronic pulmonary thromboembolism: chest radiograph and CT evaluation before and after surgery. Eur Radiol (1996) 0.98
Indirect MR arthrography: optimization and clinical applications. Radiology (1996) 0.97
Magnetic resonance spectroscopic and relaxometric determination of bone marrow changes in anorexia nervosa. Psychosom Med (2001) 0.97
Spiral CT of bronchial arteries in chronic thromboembolism. J Comput Assist Tomogr (1994) 0.97
Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia. J Gastrointest Surg (2007) 0.96
Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med (2008) 0.96
Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy. AJNR Am J Neuroradiol (2007) 0.95
Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology (1997) 0.95
Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology (2006) 0.93
Primary central nervous system immunocytoma: MRI and spectroscopy. Neuroradiology (2000) 0.92
A gene for hypotrichosis simplex of the scalp maps to chromosome 6p21.3. Am J Hum Genet (2000) 0.92
Mechanical thrombectomy compared to local-intraarterial thrombolysis in carotid T and middle cerebral artery occlusions: a single center experience. Clin Neuroradiol (2011) 0.91
MR imaging of pneumonia in immunocompromised patients: comparison with helical CT. AJR Am J Roentgenol (2000) 0.91
Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids (2005) 0.91
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett (2000) 0.91
Results of a multicenter study of the retrievable Tulip Vena Cava Filter: early clinical experience. Cardiovasc Intervent Radiol (1997) 0.90
Initial experience with lung-MRI at 3.0T: Comparison with CT and clinical data in the evaluation of interstitial lung disease activity. Eur J Radiol (2006) 0.90
A new method of MR total spine imaging for showing the brace effect in scoliosis. J Orthop Sci (2001) 0.90
Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum (1994) 0.89
Molecular imaging system for possible prediction of active retinopathy in patients with Diabetes mellitus. Amino Acids (2005) 0.89
Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology (2002) 0.88
Diagnostics of degenerative meniscal tears at 3-Tesla MRI compared to arthroscopy as reference standard. Arch Orthop Trauma Surg (2007) 0.87
Pulmonary arteries and lung parenchyma in chronic pulmonary embolism: preoperative and postoperative CT findings. Radiology (1994) 0.87
[Diagnostic imaging of vascular leiomyosarcomas]. Rofo (2004) 0.87
Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results. Eur Radiol (2010) 0.86
[Magnetic resonance imaging (MRI) of the bursa around the knee joint]. Rofo (2001) 0.85
Nonsurgical fluoroscopically guided dacryocystoplasty of common canalicular obstructions. Cardiovasc Intervent Radiol (2000) 0.85
Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids (2002) 0.84
Posterior cerebral artery Wada test: sodium amytal distribution and functional deficits. Neuroradiology (2001) 0.84
Indirect MR arthrography: techniques and applications. Eur Radiol (1998) 0.84
[Cystic renal lesions]. Rofo (2003) 0.83
Is a valgus position of the femoral component in hip resurfacing protective against spontaneous fracture of the femoral neck?: a biomechanical study. J Bone Joint Surg Br (2009) 0.83
Infantile fibromatosis of the neck with intracranial involvement: MR and CT findings. AJNR Am J Neuroradiol (1999) 0.83
[MRI of the pancreas: value of standard versus fat-suppressed pulse sequence at 0.5 T]. Rofo (1996) 0.82
Diffusion-weighted magnetic resonance imaging of breast lesions: the influence of different fat-suppression techniques on quantitative measurements and their reproducibility. Eur Radiol (2014) 0.82
[MR whole-spine recording: computer-assisted simulation of the conventional x-ray technic]. Rofo (1999) 0.82
Molecular imaging of perfusion disturbances in glaucoma. Amino Acids (2002) 0.82